CONFERENCE

 

 

World Evidence, Pricing and Access Congress is Europe’s largest congress in market access, pricing and evidence featuring 300 speakers, 8 tracks and 1500+ attendees from pharma, biotech and Payers/HTA’s.

 

COVERING ALL THE IMPORTANT TOPICS

Market Access

Evidence

Rare Diseases

Advanced Therapies

Pricing

HTA/Payer

Big Data & Digital Health

Emerging Markets

Patient Advocacy

Health Economics & Outcomes Research

 
DOWNLOAD PROSPECTUS

HALL OF FAME

 
Ana Plata
Head of Global Pricing Implementation BBU
AstraZeneca
Ana Plata speaking at World EPA
Gavin Lewis
Vice President Global Head of Market Access
Amgen
Gavin Lewis speaking at World EPA
Sandro Cesaro
Head of Europe Market Access & Pricing
AstraZeneca
Sandro Cesaro speaking at World EPA Congress
Thomas Mueller
Head of Directorate General 1 - Drugs, Medical Devices, Biotechnology
Federal Ministry of Health Germany
Thomas Mueller speaking at World EPA Congress
Elena Panitti
Global Head Real World Evidence Excellence
Novartis
Elena Panitti speaking at Pharma Pricing Market Access & Evidence Congress
Birgit Holz
Global Head of Contracting Innovation
Sanofi
Birgit Holz speaking at World EPA Congress
Goedele Van Haasteren
Staff Member
Swiss Federal Office of Public Health
Goedele Van Haasteren speaking at World EPA
Amy Israel
Vice President and Global Head, Oncology Policy & Healthcare Systems
Novartis
Amy Israel speaking at World EPA Congress
Christoph Glatzer
Chief Value and Access Officer
Janssen
Christoph Glatzer speaking at World EPA Congress
Fabienne Bartoli
Director General
HAS
Fabienne Bartoli speaking at World EPA Congress
Laurene Redding
Head, Value, Access & Policy
BeiGene
Laurene Redding speaking at World EPA Congress
Maria Kubin
Vice President, Global Integrated Evidence Generation TA CV
Bayer
Maria Kubin speaking at World EPA Congress
Francis Pang
VP, Global Market Access
Orchard Therapeutics
Francis Pang speaking at World EPA Congress
Sally Chung
VP, Head of Market Access & Pricing Europe
GSK
Sally Chung speaking at World EPA Congress
Timothy Lenehan
Corporate Vice President - Head of Global Market Access
Novo Nordisk
Timothy Lenehan speaking at World EPA Congress
Diane Kleinermans
President of the Commission of Drugs Reimbursement
National Institute for Health and Disability Insurance (INAMI-RIZIV)
Diane Kleinermans speaking at World EPA Congress
Wim Goettsch
Special Advisor HTA
Zorginstituut Nederland/National Health Care Institute Associate Professor Health Technology Assessment Ustrecht University
Wim Goettsch speaking at World EPA Congress
Marco Rauland
VP, Global Market Access and Pricing Strategic Planning
Merck
Marco Rauland speaking at World EPA Congress
Simon Shohet
VP Market Access, International
Amicus Therapeutics
Simon Shohet speaking at World EPA Congress
Enkeleida Nikai
Vice President, Global Real-World Evidence, Global Commercial Data Science
Johnson & Johnson
Enkeleida Nikai speaking at World EPA Congress
 
SEE ALL 2024 SPEAKERS


"Great networking; very useful to hear from a mix of pharma companies and payers about market access and evidence requirements"

Head Global Pricing & Market Access, Vifor Pharma


"Great opportunity to gain payer and industry insights in several 'hot' topics"

Health Care Environment Manager EU Plus, Medac


"Excellent speakers and a really good chance to network"

Director Worldwide HEOR, BMS


"This has very good coverage of the topics & a look in the future. I always get away with more solutions and creativity"

Senior Director Market Access & Pricing Generics Europe, Teva

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.

Get Involved 
 

Sponsorship & Exhibition Sales


David Boore 
david.boore@terrapinn.com
+44 20 8164 3052

Conference Production


George Mullens
george.mullens@terrapinn.com
+44 20 8164 3940

Marketing Opportunities


Diana Cobzac
diana.cobzac@terrapinn.com